"Breakthrough Galleri Blood Test Identifies 50 Cancers Through DNA Fragments"

The Galleri blood test by Grail detects 50 types of cancer through DNA fragments in blood, showing promise in early detection and improving screening methods in collaboration with the National Health Service.

• The Galleri blood test, developed by Grail, identifies circulating DNA fragments from tumors, potentially detecting 50 types of cancer in a large-scale trial involving 25,000 adults in the US and Canada.
• In the trial, nearly one in 100 participants had a positive result, and 62% of those were later confirmed to have cancer, showcasing the tests accuracy.
• The Galleri test achieved a negative predictive value exceeding 99%, effectively ruling out cancer in most cases, thus enhancing the effectiveness of current screening methods like those used by the National Health Service.